Atrás
Rango del Día
$6.92
$7.26
Rango de 52 Semanas
$2.30
$8.60
Volumen
139,339
Promedio 50D / 200D
$7.20
/
$4.62
Cierre Anterior
$7.20
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -14.5 | 0.3 |
| P/B | 8.0 | 2.9 |
| ROE % | -61.0 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.2 | 0.2 |
Precio Objetivo de Analistas
Hold
$12.00
+71.2%
EPS Futuro
-$0.50
Ingresos Est.
1.3 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$1.16
$0.61 – $1.98
|
260 M | 1 |
| FY2029 |
-$0.02
-$0.03 – -$0.01
|
91 M | 1 |
| FY2028 |
$0.07
$0.04 – $0.13
|
72 M | 1 |
Puntos Clave
Debt/Equity of 0.18 — conservative balance sheet
Negative free cash flow of -32.76M
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-61.00%
ROIC-34.92%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
0.18
Current Ratio7.45
Interest Coverage-100.93
Valoración
P/E Ratio
-14.47
P/B Ratio8.00
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -42.63M |
| ROE | -61.00% | ROA | -40.00% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -32.76M |
| ROIC | -34.92% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.18 | Current Ratio | 7.45 |
| Interest Coverage | -100.93 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -14.47 | P/B Ratio | 8.00 |
| P/S Ratio | N/A | PEG Ratio | -0.53 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 616.95M | Enterprise Value | 614.69M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -42.63M | -31.75M | -29.16M | -33.76M | -27.27M |
| EPS (Diluted) | -0.53 | -0.45 | -0.42 | -0.53 | -0.67 |
| Gross Profit | -1.23M | -1.10M | -1.07M | -979,000.0 | -776,000.0 |
| Operating Income | -42.29M | -36.04M | 35.68M | -32.14M | -13.79M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 106.58M | 86.20M | 107.39M | 120.15M | 42.22M |
| Total Liabilities | 29.48M | 23.54M | 22.91M | 14.49M | 76.99M |
| Shareholders' Equity | 77.10M | 62.67M | 84.48M | 105.66M | -34.78M |
| Total Debt | 13.73M | 12.54M | 13.28M | 5.19M | 53.96M |
| Cash & Equivalents | 15.98M | 13.72M | 12.66M | 5.84M | 23.24M |
| Current Assets | 78.30M | 64.23M | 85.76M | 106.48M | 32.64M |
| Current Liabilities | 10.51M | 8.68M | 7.10M | 4.34M | 4.41M |